Clinical research - Press Releases

Date	Title	Company
17-Jul-2020	Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020	Genmab
15-Jul-2020	NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis	NMD Pharma
15-Jul-2020	Lung cancer in non-smokers likely to respond differently to treatment	The Institute of Cancer Research
15-Jul-2020	EIT Health Wild Card winner attracts 1 million USD investment from Microsoft M12 and Mayfield	EIT Health
15-Jul-2020	OpSec Provides a COVID-19 Authenticity & Traceability Solution for Testing Kits and Pharmaceutical Products	OpSec Security
15-Jul-2020	Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU	Novartis
15-Jul-2020	Rates of bleeding and venous thromboembolism (VTE) events reported after 12 months of edoxaban ▼ treatment considered low by real-world ETNA-VTE study investigators	Daiichi Sankyo
15-Jul-2020	ARRAYJET SECURES $1MILLION BIO PRINTER CONTRACT WITH WORLD’S LARGEST PROTEIN MICROARRAY PRODUCER	Arrayjet
15-Jul-2020	Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate	Medicago
15-Jul-2020	Santhera Closes First Tranche of Financing Transaction	Santhera Pharmaceuticals
15-Jul-2020	Destiny Pharma notes launch of $1 billion pharma-backed fund to develop new anti-infectives	Destiny Pharma plc
09-Jul-2020	Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy	Anergis SA
08-Jul-2020	Next-generation Triple Antibody Test for COVID-19, developed by British company Attomarker, has been authorised by the MHRA following positive trial results	Attomarker Ltd
08-Jul-2020	Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer	AstraZeneca PLC
06-Jul-2020	EPO launches new platform to help researchers in the fight against coronavirus	The European Patent Office
06-Jul-2020	Idorsia announces positive results in the second Phase 3 study of daridorexant	Idorsia Pharmaceuticals Ltd
06-Jul-2020	Roche Diabetes Care joins forces with Boots to offer free access to mySugr Pro diabetes management app	Roche
06-Jul-2020	PHUSE Deploys NIHPO Platform of Enriched Open Data in Microsoft Azure to Accelerate COVID-19 Clinical Research	PHUSE
03-Jul-2020	Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure	Biophytis SA
03-Jul-2020	RDIF and ChemRar announce increased production of Avifavir for treatment of coronavirus and begin export deliveries	The Russian Direct Investment Fund